Relmada Therapeutics, Inc.
RLMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553643
In the last 90 days, Relmada Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $693.7M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Relmada Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 113 | 134 | +21 |
| Shares | 24.7M | 25.8M | +1.10M (+4.4%) |
| Value | $468.5M | $953.6M | +$485.2M (+103.6%) |
New holders (33)
Institutions that held Relmada Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (12)
Institutions that held Relmada Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ally Bridge Group (NY) LLC | 160,000 | $3.04M |
| Walleye Capital LLC | 106,420 | $2.02M |
| Weiss Multi-Strategy Advisers LLC | 30,000 | $570.0K |
| Dynamic Technology Lab Private Ltd | 12,951 | $246.0K |
| Jane Street Group, LLC | 12,348 | $234.0K |
| Group One Trading, L.P. | 3,354 | $64.0K |
| Captrust Financial Advisors | 1,344 | $26.0K |
| Point72 Hong Kong Ltd | 773 | $15.0K |
| Aquatic Capital Management LLC | 500 | $9.00K |
| Allspring Global Investments Holdings, LLC | 387 | $7.00K |
| Nisa Investment Advisors, LLC | 214 | $4.00K |
| State of Wyoming | 42 | $1.00K |